What an emotion to be back again to a face-to-face conference with so many colleagues and friends from the thrombosis-haemostasis-cancer community for the 11th ICTHIC in Bergamo. #icthic2022 #icthic22

Dr Kristen Sanfilippo presenting risk assessment of heme malignancies ICTHIC

Stars of ICTHIC #icthic2022 with our founding Chair Prof Falanga. The future of CAT is 🔥🔥🔥

Fantastic meeting #icthic2022 with many Ottawa 🇨🇦 colleagues and previous, new and future Italian 🇮🇹 fellows training The Ottawa Hospital. Fostering new and exciting collaborations for the prevention and management of cancer-associated thrombosis. Arrivederci nel 2024

Happy to chair with Avi Leader and present with Chiara European Hematology Association GLs on antithrombotic Rx in thrombocytopenic cancer patients

Thurs 16 June 1700 CET at eha22.ehaweb.org/eha/eha2022/en… . 📜 soon in HemaSphere Journal (IF = 14.6). Read now at ehaweb.org/assets/Uploads… .Anna Falanga Avi Leader

The Abstract submission deadline for the 12th International Conference on Thrombosis and Hemostasis issues in cancer is near! Send your scientific contributions by March 11, 2024. Check it out here: medicalhosting.org/ICTHIC/index.p… @ICTICH #thrombosis #cancer #hemostasis #12ICTHIC

Online Registration Ending Soon! 12th ICTHIC Bergamo, Italy, May 17-19, 2024 REGISTER NOW: icthic.com/congress-regis…

#ICTHIC2024 kicks off in beautiful #Bergamo with an excellent overview of Jamie O' Sullivan on roles of von Willebrand factor in #cancer angiogenesis and #metastasis linking #hemostasis and cancer in a novel perspective #thrombosis #malignancy

It's not just #VTE, @debsiegal describes the impact of stroke in people with cancer #ICTHIC24 ICTHIC ICTHIC Magazine

Fantastic 8th Simon Karpatkin Memorial Lecture at ICTHIC by Prof Agnes Lee. Interesting overview of the management of cancer-associated thrombosis highlighting an exceptional career by Prof Lee. 🏆 🎉

Day 2 of ICTHIC #ICTHIC24 kicks off with an important overview of #VTE and mortality in heme malignancies by Kristen Sanfilippo

Dr. Stanworth gave an elegant talk on the challenges in managing patients with thrombocytopenia and cancer-associated thrombosis, RCT is underway and needed! #ICTHIC2024

Closing up day#2 ICTHIC #ICTHIC24 with the one and only Simon Noble on pt/public involvement in CAT research

Great presentation by Simon Noble at #icthic24 explaining the importance of involving patients at every stage of research. #PPI is sadly neglected in #cancer associated #thrombosis research. Would be great to see patient representatives at the next @icthic?

Dr. Alok Khorana, MD highlighting that RCTs assessing Immune Checkpoint Inhibitors for patients with cancer do not capture a large majority of VTEs or ATEs (RCTs vs. Cohorts) ICTHIC meeting👇 #ICTHIC2024

Is FXI inhibition the future of the management of cancer-associated thrombosis? Dr. Marcello Di Nisio provided an elegant review ICTHIC Potentially low risk of bleeding, less drug-drug interactions, less dependence on renal/liver for elimination. Phase 3 trials on-going! Stay

Dr. Jeff Zwicker, MD demonstrated that proteomics can help to predict cancer-associated thrombosis and provide innovative mechanistic insights (through CD200R1/IL-17A axis). Looking forward seeing additional results at the ISTH meeting in Bangkok. ICTHIC

A grant finale of #ICTHIC2024 🎆Systematic review and meta-analysis by Dr. Marc Carrier et. al identified multiple risk factors for recurrent VTE in patients with cancer-associated thrombosis.

Marc Carrier GREAT Marc